Avid Bioservices, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of CDMO for the last quarter is 33.48 M USD, and it's 16.66% lower compared to the previous quarter. The net income of Q2 24 is -17.41 M USD.